# Imatinib Mesylate in Treating Patients With Recurrent Ewing's Family of Tumors or Desmoplastic Small Round-Cell Tumor

> **NCT00062205** · PHASE2 · COMPLETED · sponsor: **City of Hope Medical Center** · enrollment: 40 (estimated)

## Conditions studied

- Sarcoma

## Interventions

- **DRUG:** imatinib mesylate

## Key facts

- **NCT ID:** NCT00062205
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-06
- **Primary completion:** 2007-06
- **Final completion:** 2007-06
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2010-02-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00062205

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00062205, "Imatinib Mesylate in Treating Patients With Recurrent Ewing's Family of Tumors or Desmoplastic Small Round-Cell Tumor". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00062205. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*